The Russian Ministry of Defense (MoD) published a list of representatives of government agencies and companies from the United States and Ukraine involved in dual-use bioresearch.
The information comes from Commander of the Russian Nuclear, Biological, and Chemical Protection Troops Lt. Gen. Igor Kirillov.
Kirillov explained that MoD previously had a list of individuals in American military-biological programs, some of whom are US Department of Defense officials, biotechnology corporations and Pentagon contractors.
On the new list is Thomas Whol, the vice president of Kansas-headquartered Black & Veatch engineering company in Ukraine.
Whol oversaw the PAX electronic system for monitoring biological materials.
Kevin Olival from Eco-Health Alliance was also on the list, as he was involved in Pentagon projects for zoonotic diseases.
Mikhail Usaty, deputy head of the sanitary and epidemiological department of the Ukrainian Armed Force (UAF), and Tatyana Kiryazova, the executive director of the Ukrainian Institute of Public Health Policy, were included on the updated list.
Kirillov told reporters in another event that “Russia’s efforts to expose the US’ illegal military and biological activities as well as the deterioration of the epidemic situation in Europe-based biological facilities prodded the Biden administration to relocate the dual-use research to African countries.”
The Pentagon’s dual-use research is now conducted in the “Democratic Republic of the Congo, Sierra Leone, Cameroon, Uganda and South Africa,” according to Kirillov.
Reporting from Sputnik:
According to Kirillov, refusing to work on a verification protocol under the Biological Weapons Convention, the US “establishes administrative and technical structures that can be involved in the dual-use research, including for offensive purposes.” The Russian MoD earlier revealed that the US had spent more than $200 million to establish biological laboratories in Ukraine, which participated in the American military program. According to Moscow, Rosemont Seneca, the investment fund of Hunter Biden, took part in the financing of the projects. With Washington vehemently denying the existence of any compounds, Undersecretary of State Victoria Nuland told lawmakers last year that "biological research facilities" linked to the US were in fact operating in Ukraine.
